← back to search

Andreas Brandl

Heidelberg University · DE
Area of research
Surgery · Ocean Engineering
Research interest
Research interests include Intraperitoneal and Appendiceal Malignancies, Drilling and Well Engineering, Ovarian cancer diagnosis and treatment, and Oil and Gas Production Techniques.
h-index
33
citations
3,539
works
274
NIH funding
primary concept
email

Recent publications

Neoadjuvant treatment of colorectal cancer: comprehensive review
BJS Open 2024cited by 71position: middledoi
Effect of Hyperthermic Intraperitoneal Chemotherapy on Cytoreductive Surgery in Gastric Cancer With Synchronous Peritoneal Metastases: The Phase III GASTRIPEC-I Trial
Journal of Clinical Oncology 2023cited by 126position: middledoi
Is PIPAC a Treatment Option in Upper and Lower Gastrointestinal Cancer with Peritoneal Metastasis?
Visceral Medicine 2022cited by 6position: lastdoi
1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)
Annals of Oncology 2021cited by 37position: middledoi
Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols
European Journal of Surgical Oncology 2021cited by 33position: middledoi
Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study
Annals of Surgical Oncology 2021cited by 29position: middledoi
The ESSO core curriculum committee update on surgical oncology
European Journal of Surgical Oncology 2021cited by 21position: middledoi
Systemic Chemotherapy Including Ramucirumab in Combination With Pressurized Intra-Peritoneal Aerosol Chemotherapy Is a Safe Treatment Option for Peritoneal Metastasis of Gastric Cancer
Frontiers in Oncology 2021cited by 17position: middledoi
Peritoneal metastasis of colorectal cancer (pmCRC): identification of predictive molecular signatures by a novel preclinical platform of matching pmCRC PDX/PD3D models
Molecular Cancer 2021cited by 10position: middledoi
Transplantation programs facing lack of empirical evidence on SARS‐CoV‐2 vaccination: A society recommendation consensus update
Transplant Infectious Disease 2021cited by 5position: middledoi
Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approach
American Journal of Transplantation 2020cited by 109position: middledoi
Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification?
European Journal of Surgical Oncology 2020cited by 44position: middledoi
Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview
Clinical & Experimental Metastasis 2019cited by 21position: middledoi
Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion
The Journal of Experimental Medicine 2016cited by 154position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Beate Rau · Klinikum im Friedrichshain6 papers (2019–2022)Johann Pratschke · Johnson & Johnson (United States)4 papers (2020–2021)Leke Wiering · Charité - Universitätsmedizin Berlin2 papers (2020–2021)Ulrike Stein · German Cancer Research Center2 papers (2019–2021)Linda Feldbrügge · Medizinische Hochschule Hannover2 papers (2021–2021)Paul Viktor Ritschl · Charité - Universitätsmedizin Berlin2 papers (2020–2021)Miguel Enrique Alberto Vílchez · Max Delbrück Center2 papers (2021–2022)Helen Wu · Humboldt-Universität zu Berlin2 papers (2020–2021)Nora Nevermann · Medizinische Hochschule Hannover2 papers (2020–2021)Mathias Dahlmann · German Cancer Research Center2 papers (2019–2021)Moritz Schmelzle · Medizinische Hochschule Hannover2 papers (2020–2021)Felix Gronau · Medizinische Hochschule Hannover2 papers (2021–2021)Wenzel Schöning · Humboldt-Universität zu Berlin2 papers (2020–2021)Safak Gül‐Klein · Humboldt-Universität zu Berlin2 papers (2019–2021)Robert Öllinger · Freie Universität Berlin2 papers (2020–2021)Philipp Moroder · Schulthess-Klinik2 papers (2020–2021)Peter Thuss‐Patience · Universität Hamburg2 papers (2021–2021)Safak Guel‐Klein · Charité - Universitätsmedizin Berlin1 papers (2022–2022)Frank Tacke · Charité University Medicine Berlin1 papers (2020–2020)Eva Pachmayr · Charité - Universitätsmedizin Berlin1 papers (2021–2021)